Back

STELA (systematic technology for enhanced longevity and atherosclerosis prevention): development and initial implementation of a novel platform for population-based primary cardiovascular prevention

4 April 2025 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Screening for cardiovascular risk: best practice Cardiovascular Risk Assessment EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Bogna Jiravska Godula

Hospital Podlesi, Trinec (Czechia)

6 More presentations in this session

Presentation thumbnail
Population-wide cardiovascular and metabolic screening using point-of-care capillary testing: insights from the UNISCREEN pilot study.
Doctor A. Merolla (Milan, IT)
Abstract Slides
Presentation thumbnail
Innovative cardiovascular secondary prevention registry: harnessing real-world data for Big Data integration and personalized care
Assistant Professor D. Trache (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Detection of subclinical carotid plaques in ultrasound images using novel anomaly detection approach - towards improved tools for cardiovascular prevention
Doctor A. Saboori (Umea, SE)
Abstract Slides
Presentation thumbnail
Artificial intelligence models using sinus rhythm electrocardiography for proactive atrial fibrillation screening: a comprehensive systematic review
Doctor E. Tsiartas (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Can an AI-powered smartphone application estimate pulmonary hypertension by taking a 12-lead ECG of Japanese patients?
Doctor K. Sone (Kawasaki, JP)
Abstract Slides

Access the full session

Session thumbnail
Screening for cardiovascular risk: best practice

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 11:00 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources